Top 5 stocks in focus on July 3: Hero Motocorp, NCC to Fortis Healthcare; here are the 5 newsmakers of the day

The benchmark S&P BSE Sensex fell by 159.07 (-0.45%) to close at 35,264.41 and same was the situation with Nifty 50 and BankNifty as they to ended in a red on July 2, 2018, the first day of trade of the month. But amid this fall, there were certain stocks that came in the news due to certain reasons and the reflections will be seen on the market on July 3, 2018. Here are the stocks concerned: 

Hero MotoCorp: The world largest two-wheeler manufacturing company reported a 13 per cent growth in June sale at 7,04,562 units over the 624,185 units sold in June 2017, while its first-quarter sales crossed 2.1 million units.

Strides Shasun: The drug firm has received approval from the United States Food & Drug Administration (USFDA) for anti-inflammatory Ibuprofen tablets and for Milnacipran Hydrochloride tablets used for treating pain due to a certain condition.

Dr Reddy's Laboratories Ltd: The drugmaker on Monday announced that it has launched Repatha (evolocumab) 140 mg/ml, the first and only PCSK9 Inhibitor available in India, approved by the Drug Controller General India (DCGI).

NCC: The company has received four new orders totalling Rs 2060.96 core. Out of this, three orders totalling to Rs. 1997.51 crore pertain to Buildings Division and one order of Rs. 63.45 crore pertain to Water & Environment Division. All these orders are received from various central and state government agencies and do not include any internal orders. In the first three months of the current financial year, the company has received new orders of Rs 3668.78 crore till June 2018.

Watch this Zee Business video here:

 
Fortis Healthcare: Today is the last day for submission of binding bids for Fortis Healthcare’s business.